Clinical Effectiveness and Health Economic Evaluation of Eluvia Drug-eluting Stent in the Treatment of Femoropopliteal Artery Lesions
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
This study is a multicenter, prospective, observational study, aiming to enroll 400 patients with peripheral arterial disease in the femoral-popliteal segment implanted with Eluvia stent. Each patient was followed up for 2 years. The technical success rate, target lesion patency rate, quality of life improvement, cost of Eluvia stent implantation, and other outcomes will be analysed.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Rutherford Stage 2-5.
• At least 90% stenosis or occlusion of the femoropopliteal artery.
• Eluvia stents are used for target lesions.
• Agree and sign the informed consent form
Locations
Other Locations
China
First Affiliated Hospital of Zhejiang University
RECRUITING
Hangzhou
Time Frame
Start Date: 2022-08-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 400
Related Therapeutic Areas
Sponsors
Leads: First Affiliated Hospital of Zhejiang University